Literature DB >> 1422760

Smoking predisposes to parotid adenolymphoma.

M Cadier1, G Watkin, M Hobsley.   

Abstract

Of 574 patients with previously untreated, unremarkable parotid lumps, 194 proved to have pleomorphic adenomas and 73 adenolymphomas. ABO blood group details were available in 59 and 85 per cent of patients respectively. Smoking details were available in 84 per cent of a randomly chosen 46 per cent subgroup of patients with pleomorphic adenomas and in 86 per cent of all those with adenolymphomas. The incidences of smoking and of the ABO blood groups in these two diagnoses were compared with standard sources. There was no evidence that either histological diagnosis of parotid tumours was linked to an abnormal pattern of ABO blood groups. However, there was a much greater incidence of smoking among the adenolymphoma than in the pleomorphic adenoma group: only one of 63 patients with adenolymphoma as opposed to 31 of 75 with pleomorphic adenoma had never smoked, while the mean number of cigarettes smoked by each patient with an adenolymphoma was estimated to be 300,000 as opposed to 80,000 for those with pleomorphic adenoma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1422760     DOI: 10.1002/bjs.1800790925

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  3 in total

1.  ABO blood groups and salivary gland tumors (Alabama, United States).

Authors:  J A Pinkston; P Cole
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

2.  Multiple malignant salivary gland neoplasms: mucoepidermoid carcinoma of palate and adenoid cystic carcinoma of floor of mouth.

Authors:  Joseph C Whitt; Duane R Schafer; Michael D Callihan
Journal:  Head Neck Pathol       Date:  2007-12-06

3.  Changing frequency of parotid gland neoplasms--analysis of 560 tumours treated in a district general hospital.

Authors:  M Ethunandan; C A Pratt; D W Macpherson
Journal:  Ann R Coll Surg Engl       Date:  2002-01       Impact factor: 1.891

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.